Hypermarcas (OTCMKTS:HYPMY) Stock Price Down 6.3% - What's Next?

Key Points

• Hypermarcas stock experienced a significant decline of 6.3% during trading, with shares last trading at $4.03 and a dramatic decline in trading volume.
• Analysts at Scotiabank have upgraded Hypermarcas to a "strong-buy" rating, indicating potential growth despite the stock's recent performance.
• The company is planning to distribute a dividend of $0.0345 per share on January 8th, representing a yield of 281.0%.

Shares of Hypermarcas (OTCMKTS:HYPMY - Get Free Report) dropped 6.3% during trading on Tuesday . The stock traded as low as $4.03 and last traded at $4.03. Approximately 1,307 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 65,768 shares. The stock had previously closed at $4.30.

Analyst Upgrades and Downgrades

Separately, Scotiabank upgraded shares of Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th.

Hypermarcas Price Performance

The company has a fifty day simple moving average of $4.72 and a two-hundred day simple moving average of $4.02. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26. The company has a market capitalization of $2.68 billion, a price-to-earnings ratio of 20.12 and a beta of 0.77.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.12 earnings per share for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

Hypermarcas Dividend Announcement

The business also recently declared a dividend, which will be paid on Friday, January 8th. Shareholders of record on Tuesday, July 1st will be issued a $0.0345 dividend. This represents a dividend yield of 281.0%. The ex-dividend date is Monday, June 30th. Hypermarcas's dividend payout ratio (DPR) is 57.14%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.